STEPHEN LONG: Open Payments
NPI 1710211891 · HIXSON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,886 in 103 payments from 23 companies in 2025. Trend: 2023 $2,056 · 2024 $2,174 · 2025 $1,886
Food & beverage: $1,886
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $278 |
| AstraZeneca Pharmaceuticals LP | 12 | $220 |
| ABBVIE INC. | 13 | $214 |
| Amgen Inc. | 13 | $167 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $131 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $124 |
| GlaxoSmithKline, LLC. | 6 | $107 |
| PFIZER INC. | 6 | $106 |
| Abbott Laboratories | 3 | $64 |
| Janssen Pharmaceuticals, Inc | 2 | $62 |
Products named: AIRSUPRA, JARDIANCE, Kerendia, Rybelsus, Ozempic, OTEZLA, FARXIGA, VRAYLAR.
Industry payments across TN — which companies pay providers there.
